Colombia Completed the First Export of Cannabis Sativa Dried Flower to North Macedonia

The first to complete the export batch of cannabis sativa dried flower from the Alfonso Bonilla Aragón Airport, in Cali, was the company Earth’s Healing Colombia SAS.

The company managed to export 400 kilograms of dried cannabis sativa flower, distributed in 800 vacuum-sealed bags. This product will be used with a medicinal approach through the extraction of its oils, for the production of new products.

The ICA, who also accompanied the management, generated the phytosanitary certificate for the export of plant material , through physical inspection of the product to evaluate the absence of phytosanitary risk, that is, that the flowers do not have visible pests or diseases that could affect the phytosanitary status of the destination country.

If you want to find more details about the cannabis sativa dried flowers export from Colombia to North Macedonia, download for free the Hemp.im mobile app. The app keeps its readers up to date with the most important cannabis news of the day so they can stay on top of the market.

What were the cannabis sativa dried flower export requirements for North Macedonia?

The exporter must present all of the merchandise at the place of departure of the shipment for physical inspection by the ICA official, who will validate the phytosanitary quality of the plant material, the absence of quarantine pests for the country.

The packaging used must be correctly labeled and be new and first used , in order to prevent the possibility of contamination.

In turn, according to Joint Resolution 539 of 2022, for the export of cannabis sativa, the exporter must request approval from the ICA. This approval, to which it refers, is related to the National Registry of Commercial Cultivars, Rncc.

According to the ICA, there are more than 60 exports of this product made in the country.
Precisely in April 2022, this Resolution issued by the Ministries of Commerce, Justice and Agriculture arrived, and has allowed the movement of more shipments to demanding countries such as Australia, Switzerland and Germany.

On February 9th, 2016, North Macedonia legalized the cultivation and export of medical cannabis, distinguishing itself as one of the select nations with such legal provisions. Unlike many European countries, North Macedonia has adopted a decentralized approach, modeled after Canada’s system, allowing private companies to innovate and compete in producing cannabis-based products. This approach fuels optimism among industry insiders, positioning North Macedonia to emerge as a prominent exporter of medicinal cannabis products in Europe.

__

(Featured image by dimitrisvetsikas1969 via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in AGRONEGOCIOS. A third-party contributor translated and adapted the articles from the originals. In case of discrepancy, the originals will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us